rs3024405

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000129.4(F13A1):​c.973+937A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.458 in 151,688 control chromosomes in the GnomAD database, including 16,698 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 16698 hom., cov: 30)

Consequence

F13A1
NM_000129.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.09

Publications

2 publications found
Variant links:
Genes affected
F13A1 (HGNC:3531): (coagulation factor XIII A chain) This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13A1 Gene-Disease associations (from GenCC):
  • factor XIII, A subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.635 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000129.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13A1
NM_000129.4
MANE Select
c.973+937A>T
intron
N/ANP_000120.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13A1
ENST00000264870.8
TSL:1 MANE Select
c.973+937A>T
intron
N/AENSP00000264870.3
F13A1
ENST00000950947.1
c.973+937A>T
intron
N/AENSP00000621006.1
F13A1
ENST00000878383.1
c.784+937A>T
intron
N/AENSP00000548442.1

Frequencies

GnomAD3 genomes
AF:
0.458
AC:
69425
AN:
151572
Hom.:
16664
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.577
Gnomad AMI
AF:
0.380
Gnomad AMR
AF:
0.372
Gnomad ASJ
AF:
0.480
Gnomad EAS
AF:
0.652
Gnomad SAS
AF:
0.512
Gnomad FIN
AF:
0.410
Gnomad MID
AF:
0.618
Gnomad NFE
AF:
0.393
Gnomad OTH
AF:
0.461
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.458
AC:
69517
AN:
151688
Hom.:
16698
Cov.:
30
AF XY:
0.461
AC XY:
34118
AN XY:
74084
show subpopulations
African (AFR)
AF:
0.577
AC:
23871
AN:
41336
American (AMR)
AF:
0.372
AC:
5672
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.480
AC:
1662
AN:
3466
East Asian (EAS)
AF:
0.653
AC:
3368
AN:
5158
South Asian (SAS)
AF:
0.513
AC:
2459
AN:
4798
European-Finnish (FIN)
AF:
0.410
AC:
4301
AN:
10482
Middle Eastern (MID)
AF:
0.637
AC:
186
AN:
292
European-Non Finnish (NFE)
AF:
0.393
AC:
26679
AN:
67902
Other (OTH)
AF:
0.463
AC:
973
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1838
3676
5515
7353
9191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
642
1284
1926
2568
3210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.412
Hom.:
1630
Bravo
AF:
0.455
Asia WGS
AF:
0.574
AC:
1994
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.5
DANN
Benign
0.71
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3024405; hg19: chr6-6223982; API